SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Amarin Corporation - AMRN

Wednesday, November 14, 2018 General News
Email Print This Page Comment bookmark
Font : A-A+

NEW YORK, Nov. 13, 2018 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Amarin Corporation

plc ("Amarin" or the "Company") (NASDAQ: AMRN).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 9980.

The investigation concerns whether Amarin and

certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934.

[Click here to join a class action]

On November 12, 2018, Seeking Alpha published an article by contributor DoctoRx, entitled "Amarin's REDUCE-IT Trial: Something Fishy?"  The article addressed Amarin's "recent revelations of positive topline results" from its REDUCE-IT trial for Vascepa, its sole product.  Specifically, the article raised the possibility that "the placebo group received an active agent that in effect was an anti-statin", and that the REDUCE-IT trial results may have consequently exaggerated the efficacy of Vascepa.  Following this news, Amarin's American depositary receipt price fell sharply during intraday trading on November 13, 2018.

The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:Robert S. WilloughbyPomerantz LLPrswilloughby@pomlaw.com888-476-6529 ext. 9980

 

Cision View original content:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-amarin-corporation--amrn-300749564.html

SOURCE Pomerantz LLP



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store